Alkermes Plc at Goldman Sachs Healthcare Conference Transcript
Good morning, everyone. Thanks for joining us here on the third day of the Goldman Sachs Global Healthcare Conference. And thanks to everyone who joined us here as well as online. We're thrilled to be joined today by Richard Pops, Chairman and Chief Executive Officer; and Blair Jackson, Executive Vice President and Chief Operating Officer for Alkermes.
Maybe first, just over the last 12 months, you've seen a significant period of change for Alkermes, including validation of the orexin agonist class, an acquisition of Avadel, the announced CEO transition. So thanks for joining us. But before we jump into Q&A, I'd love to just turn it to you for some opening remarks on all that progress.
Well, thanks for having us, first of all. And standing room only in this giant room is great to see.
You don't know how to deal online --
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
